Intravascular Imaging–Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials
Articolo
Data di Pubblicazione:
2024
Citazione:
Intravascular Imaging–Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials / Sreenivasan, J.; Reddy, R. K.; Jamil, Y.; Malik, A.; Chamie, D.; Howard, J. P.; Nanna, M. G.; Mintz, G. S.; Maehara, A.; Ali, Z. A.; Moses, J. W.; Chen, S. -L.; Chieffo, A.; Colombo, A.; Leon, M. B.; Lansky, A. J.; Ahmad, Y.. - In: JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE. - ISSN 2047-9980. - 13:2(2024). [10.1161/JAHA.123.031111]
Abstract:
BACKGROUND: Despite the initial evidence supporting the utility of intravascular imaging to guide percutaneous coronary intervention (PCI), adoption remains low. Recent new trial data have become available. An updated study-level meta-analysis comparing intravascular imaging to angiography to guide PCI was performed. This study aimed to evaluate the clinical outcomes of intravascular imaging–guided PCI compared with angiography-guided PCI. METHODS AND RESULTS: A random-effects meta-analysis was performed on the basis of the intention-to-treat principle. The primary outcomes were major adverse cardiac events, cardiac death, and all-cause death. Mixed-effects meta-regression was performed to investigate the impact of complex PCI on the primary outcomes. A total of 16 trials with 7814 patients were included. The weighted mean follow-up duration was 28.8 months. Intravascular imaging led to a lower risk of major adverse cardiac events (relative risk [RR], 0.67 [95% CI, 0.55–0.82]; P<0.001), cardiac death (RR, 0.49 [95% CI, 0.34–0.71]; P<0.001), stent thrombosis (RR, 0.63 [95% CI, 0.40–0.99]; P=0.046), target-lesion revascularization (RR, 0.67 [95% CI, 0.49–0.91]; P=0.01), and target-vessel revascularization (RR, 0.60 [95% CI, 0.45–0.80]; P<0.001). In complex lesion subsets, the point estimate for imaging-guided PCI compared with angiography-guided PCI for all-cause death was a RR of 0.75 (95% CI, 0.55–1.02; P=0.07). CONCLUSIONS: In patients undergoing PCI, intravascular imaging is associated with reductions in major adverse cardiac events, cardiac death, stent thrombosis, target-lesion revascularization, and target-vessel revascularization. The magnitude of benefit is large and consistent across all included studies. There may also be benefits in all-cause death, particularly in complex lesion subsets. These results support the use of intravascular imaging as standard of care and updates of clinical guidelines.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
intravascular ultrasound; meta-analysis; optical coherence tomography; percutaneous coronary intervention
Elenco autori:
Sreenivasan, J.; Reddy, R. K.; Jamil, Y.; Malik, A.; Chamie, D.; Howard, J. P.; Nanna, M. G.; Mintz, G. S.; Maehara, A.; Ali, Z. A.; Moses, J. W.; Chen, S. -L.; Chieffo, A.; Colombo, A.; Leon, M. B.; Lansky, A. J.; Ahmad, Y.
Link alla scheda completa:
Pubblicato in: